Oleander Extract Glioblastoma Study Retracted Over Image Integrity Concerns
Frontiers in Pharmacology has retracted a 2020 study on the oleander-derived drug PBI-05204 for glioblastoma after image integrity concerns and ...
Frontiers in Pharmacology has retracted a 2020 study on the oleander-derived drug PBI-05204 for glioblastoma after image integrity concerns and ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.